Differential impact of on-site or telepharmacy in the intensive care unit: a controlled before–after study

João Gabriel Rosa Ramos(D’Or Institute for Research and Education), Ana Verena Almeida Mendes(Escola Bahiana de Medicina e Saúde Pública), Rogério da Hora Passos(Yahoo (Spain)), Juliana Caldas(Escola Bahiana de Medicina e Saúde Pública), Sandra Cristina Hernandes(Hospital São Rafael), Shana Oliveira(D’Or Institute for Research and Education), Talita Teles Teixeira Pereira(Hospital São Rafael), Denis de Melo Soares(Universidade Federal da Bahia), Paulo Benígno Pena Batista(D’Or Institute for Research and Education), Suzete Nascimento Farias da Guarda(Universidade Federal da Bahia)
International Journal for Quality in Health Care
January 1, 2021
10.1093/intqhc/mzab011
Cited by 6

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
|The Lancet|2022|467
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil
|Emerging infectious diseases|2021|215
Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial
|Biomedicine & Pharmacotherapy|2021|121